Plasma calcium as a predictor of cardiovascular disease in a community-based cohort

Clinical Endocrinology

Volumn 78, Issue 6, 2013, Pages 852-857

  Walsh, John P ^a,b   Divitini, Mark L ^c   Knuiman, Matthew W ^c  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; CHOLESTEROL; GLUCOSE;

ADULT; AGED; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMMUNITY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM; CARDIOVASCULAR DISEASES; COHORT STUDIES; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; WESTERN AUSTRALIA;

EID: 84876525600     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12081     Document Type: Article

References (36)

1. Ward, B.K., Magno, A.L., Walsh, J.P., et al,. (2012) The role of the calcium-sensing receptor in human disease. Clinical Biochemistry, 45, 943-953.
2. Silverberg, S.J., Lewiecki, E.M., Mosekilde, L., et al,. (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Journal of Clinical Endocrinology and Metabolism, 94, 351-365.
3. Ljunghall, S., Jakobsson, S., Joborn, C., et al,. (1991) Longitudinal studies of mild primary hyperparathyroidism. Journal of Bone and Mineral Research, 6 (Suppl 2), S111-S116; discussion S121-114.
4. Lundgren, E., Lind, L., Palmer, M., et al,. (2001) Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery, 130, 978-985.
5. Yu, N., Donnan, P.T., &, Leese, G.P., (2011) A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clinical Endocrinology, 75, 169-176.
6. Wermers, R.A., Khosla, S., Atkinson, E.J., et al,. (1998) Survival after the diagnosis of hyperparathyroidism: a population-based study. American Journal Of Medicine, 104, 115-122.
7. Young, E.W., Albert, J.M., Satayathum, S., et al,. (2005) Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney International, 67, 1179-1187.
8. Palmer, S.C., Hayen, A., Macaskill, P., et al,. (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA, 305, 1119-1127.
9. Foley, R.N., (2007) Phosphorus comes of age as a cardiovascular risk factor. Archives of Internal Medicine, 167, 873-874.
10. Leifsson, B.G., &, Ahren, B., (1996) Serum calcium and survival in a large health screening program. Journal of Clinical Endocrinology and Metabolism, 81, 2149-2153.
11. Larsson, T.E., Olauson, H., Hagstrom, E., et al,. (2010) Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 333-339.
12. Lind, L., Skarfors, E., Berglund, L., et al,. (1997) Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. Journal of Clinical Epidemiology, 50, 967-973.
13. Dhingra, R., Sullivan, L.M., Fox, C.S., et al,. (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Archives of Internal Medicine, 167, 879-885.
14. Foley, R.N., Collins, A.J., Ishani, A., et al,. (2008) Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. American Heart Journal, 156, 556-563.
15. Lind, L., Jakobsson, S., Lithell, H., et al,. (1988) Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ, 297, 960-963.
16. De Bacquer, D., De Henauw, S., De Backer, G., et al,. (1994) Epidemiological evidence for an association between serum calcium and serum lipids. Atherosclerosis, 108, 193-200.
17. Jorde, R., Sundsfjord, J., Fitzgerald, P., et al,. (1999) Serum calcium and cardiovascular risk factors and diseases: the Tromso study. Hypertension, 34, 484-490.
18. Slinin, Y., Blackwell, T., Ishani, A., et al,. (2011) Serum calcium, phosphorus and cardiovascular events in post-menopausal women. International Journal of Cardiology, 149, 335-340.
19. Guessous, I., Bonny, O., Paccaud, F., et al,. (2011) Serum calcium levels are associated with novel cardiometabolic risk factors in the population-based CoLaus study. PLoS ONE, 6, e18865.
20. Williams, D.M., Fraser, A., &, Lawlor, D.A., (2011) Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents. Heart, 97, 315-320.
21. Hagstrom, E., Hellman, P., Lundgren, E., et al,. (2007) Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia, 50, 317-324.
22. Bolland, M.J., Avenell, A., Baron, J.A., et al,. (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ, 341, c3691.
23. Bolland, M.J., Grey, A., Avenell, A., et al,. (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ, 342, d2040.
24. Elder, G.J., (2011) Calcium supplementation: lessons from the general population for chronic kidney disease and back. Current Opinion in Nephrology and Hypertension, 20, 369-375.
25. Avenell, A., MacLennan, G.S., Jenkinson, D.J., et al,. (2012) Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). Journal of Clinical Endocrinology and Metabolism, 97, 614-622.
26. Li, K., Kaaks, R., Linseisen, J., et al,. (2012) Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart, 98, 920-925.
27. Lewis, J.R., Calver, J., Zhu, K., et al,. (2011) Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. Journal of Bone and Mineral Research, 26, 35-41.
28. Reid, I.R., Bolland, M.J., &, Grey, A., (2010) Does calcium supplementation increase cardiovascular risk? Clinical Endocrinology, 73, 689-695.
29. Hung, J., Knuiman, M.W., Divitini, M.L., et al,. (2008) Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. The American Journal of Cardiology, 101, 193-198.
30. Levey, A.S., Bosch, J.P., Lewis, J.B., et al,. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine, 130, 461-470.
31. Daly, R.M., Gagnon, C., Lu, Z.X., et al,. (2012) Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clinical Endocrinology, 77, 26-35.
32. Holman, C.D., Bass, A.J., Rosman, D.L., et al,. (2008) A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Australian Health Review, 32, 766-777.
33. Grandi, N.C., Brenner, H., Hahmann, H., et al,. (2012) Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart, 98, 926-933.
34. Thompson, B., &, Towler, D.A., (2012) Arterial calcification and bone physiology: role of the bone-vascular axis. Nature Reviews. Endocrinology, 8, 529-543.
35. Shin, S., Kim, K.J., Chang, H.J., et al,. (2012) Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. European Heart Journal, doi: 10.1093/eurheartj/ehs152. Epub 27 June 2012.
36. Ong, G.S., Walsh, J.P., Stuckey, B.G., et al,. (2012) The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 97, 3138-3145.